國立虎尾科技大學 |

COPD = heterogeneity and personalized treatment /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	COPD/ edited by Sang-Do Lee.
其他題名:	heterogeneity and personalized treatment /
其他作者:	Lee, Sang-Do.
出版者:	Berlin, Heidelberg :Springer Berlin Heidelberg : : 2017.,
面頁冊數:	viii, 341 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
標題:	Lungs - Diseases, Obstructive. -
電子資源:	http://dx.doi.org/10.1007/978-3-662-47178-4
ISBN:	9783662471784

COPD = heterogeneity and personalized treatment /
COPDheterogeneity and personalized treatment /[electronic resource] :edited by Sang-Do Lee. - Berlin, Heidelberg :Springer Berlin Heidelberg :2017. - viii, 341 p. :ill., digital ;24 cm.

Overview -- Introduction: Summary -- Definition -- Epidemiology -- Risk Factors -- Pathology/Pathogenesis/Pathophysiology -- Assessment -- Introduction: Summary -- Symptoms: SGRQ, CAT, MRC -- Spirometry -- Images -- Biomarkers -- Comorbidity -- Heterogeneity -- Introduction: Summary -- Phenotypes of COPD -- Genetics -- Images -- ACOS -- Exacerbation -- Pulmonary Hypertension -- Management -- Introduction: Summary -- Prevention -- Pharmacologic -- Non-pharmacologic: LVR, Rehab, Nutritional support -- Management of exacerbation -- Management of Comorbidities -- Personalized Treatment: current practice and evidences from researches -- Prospective -- Cohort: KOLD, ANOLD; Big data, Network medicine.

This book explains how analysis of the heterogeneity of chronic obstructive pulmonary disease (COPD) enhances understanding of the condition and leads to improved, personalized treatment. State of the art knowledge is presented on a range of issues related to the heterogeneity of COPD, such as phenotypes (clinical, physiologic, radiologic, etc.), genotypes, and the tools to be used for dissecting heterogeneity (CT, MRI, biomarkers, etc.) Especially modern radiologic imaging holds promise in this context, and its role is described in detail with the aid of numerous ill.. The implications of the heterogeneity for personalized treatment are clearly identified, with description of an appropriate tailored treatment strategy for each subgroup of patients. Information is provided on both current and emerging strategies, including bronchoscopic lung volume reduction and approaches to the management of pulmonary hypertension and comorbidities. This book will be a great asset In clinical practice and research for all who have an interest in COPD, a leading cause of morbidity and mortality worldwide.

ISBN: 9783662471784

Standard No.: 10.1007/978-3-662-47178-4doiSubjects--Topical Terms:

783777
Lungs
--Diseases, Obstructive.

LC Class. No.: RC776.O3

Dewey Class. No.: 616.24

COPD = heterogeneity and personalized treatment /
LDR:02740nam a2200313 a 4500 001 905346
003 DE-He213
005 20171010164004.0
006 m d
007 cr nn 008maaau
008 190308s2017 gw s 0 eng d
020 $a 9783662471784 $q (electronic bk.)
020 $a 9783662471777 $q (paper)
024 7 $a 10.1007/978-3-662-47178-4 $2 doi
035 $a 978-3-662-47178-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC776.O3
072 7 $a MJL $2 bicssc
072 7 $a MED079000 $2 bisacsh
082 0 4 $a 616.24 $2 23
090 $a RC776.O3 $b C781 2017
245 0 0 $a COPD $h [electronic resource] : $b heterogeneity and personalized treatment / $c edited by Sang-Do Lee.
260 $a Berlin, Heidelberg : $c 2017. $b Springer Berlin Heidelberg : $b Imprint: Springer,
300 $a viii, 341 p. : $b ill., digital ; $c 24 cm.
505 0 $a Overview -- Introduction: Summary -- Definition -- Epidemiology -- Risk Factors -- Pathology/Pathogenesis/Pathophysiology -- Assessment -- Introduction: Summary -- Symptoms: SGRQ, CAT, MRC -- Spirometry -- Images -- Biomarkers -- Comorbidity -- Heterogeneity -- Introduction: Summary -- Phenotypes of COPD -- Genetics -- Images -- ACOS -- Exacerbation -- Pulmonary Hypertension -- Management -- Introduction: Summary -- Prevention -- Pharmacologic -- Non-pharmacologic: LVR, Rehab, Nutritional support -- Management of exacerbation -- Management of Comorbidities -- Personalized Treatment: current practice and evidences from researches -- Prospective -- Cohort: KOLD, ANOLD; Big data, Network medicine.
520 $a This book explains how analysis of the heterogeneity of chronic obstructive pulmonary disease (COPD) enhances understanding of the condition and leads to improved, personalized treatment. State of the art knowledge is presented on a range of issues related to the heterogeneity of COPD, such as phenotypes (clinical, physiologic, radiologic, etc.), genotypes, and the tools to be used for dissecting heterogeneity (CT, MRI, biomarkers, etc.) Especially modern radiologic imaging holds promise in this context, and its role is described in detail with the aid of numerous ill.. The implications of the heterogeneity for personalized treatment are clearly identified, with description of an appropriate tailored treatment strategy for each subgroup of patients. Information is provided on both current and emerging strategies, including bronchoscopic lung volume reduction and approaches to the management of pulmonary hypertension and comorbidities. This book will be a great asset In clinical practice and research for all who have an interest in COPD, a leading cause of morbidity and mortality worldwide.
650 0 $a Lungs $x Diseases, Obstructive. $3 783777
650 1 4 $a Medicine & Public Health. $3 593949
650 2 4 $a Pneumology/Respiratory System. $3 668561
650 2 4 $a Pathology. $3 668553
650 2 4 $a Diagnostic Radiology. $3 593950
700 1 $a Lee, Sang-Do. $3 1172421
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-662-47178-4
950 $a Medicine (Springer-11650)